Hutch News

Hutch News

Stories tagged 'Barry L Stoddard'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 19, 2015 | By Fred Hutch News Service staff

More than a dozen Fred Hutch scientists and staff participated in the ninth annual Life Sciences Research Weekend Nov. 6-8 at Pacific Science Center in Seattle. Read about this and more Good News at Fred Hutch.

View story >

New strategy could prevent GMO leaks from lab to the wild

Scientists rewrite bacterium’s genetic language so it can’t survive outside the lab

Jan. 27, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Scientists have crafted a bacterium incapable of surviving without human assistance. Using this strategy to build genetically modified organisms would prevent those GMOs from escaping into natural ecosystems, they say.

View story >

‘Outrageous experience’: Researchers recall pioneering experiments on Soviet space station

Drs. Roland Strong and Barry Stoddard were part of the first U.S. group to launch scientific experiments 25 years ago on the Soviet space station

Dec. 18, 2014 | By Susan Keown / Fred Hutch News Service

Twenty-five years ago this month, Barry Stoddard, Roland Strong and their team members working with the U.S. company Payload Systems, Inc., launched the first-ever commercial American cargo up to the Soviet space station Mir, an event that gained global attention.

View story >

Shredding the X chromosome: Wiping out female malaria-bearing mosquitos could halt disease

Scientists genetically modify mosquito responsible for spreading malaria so bugs produce mostly male offspring

June 27, 2014 | By Dr. Rachel Tompa

Scientists from Imperial College London and Fred Hutchinson Cancer Research Center have genetically modified the mosquito responsible for spreading malaria so the bugs produce mostly male offspring, a strategy that could eliminate the insect responsible for Africa's malaria plague.

View story >

Team solves structure of promising gene-targeting protein

Barry Stoddard and colleagues are first to show TAL effector structure, paving way for use in gene modification, engineering and corrective therapy

Jan. 9, 2012 | By Kristen Woodward

Fred Hutchinson Cancer Research Center researchers have solved the three-dimensional structure of a newly discovered type of gene-targeting protein shown to be useful as a DNA-targeting molecule for gene correction, gene therapy and gene modification. The findings were published online in Science Express on Jan. 5.

View story >

Funds for innovative gene therapy

Hans-Peter Kiem, Barry Stoddard receive $5.2 million NIH grant

Oct. 1, 2007

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.